Prime Medicine, Inc.PRMENASDAQ
Loading
Revenue ScalingExpanding
Percentile Rank83
5Y CAGR-2.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

5Y CAGR
-2.3%/yr
Long-term compound
Percentile
P83
Within normal range
vs 5Y Ago
0.9x
Contraction
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$4.63M+55.3%
2024$2.98M-
2023$0.00-
2022$0.00-
2021$0.00-100.0%
2020$5.21M-
2019$0.00-